Robo2: A Potential Drug Target and Biomarker (G6092)
Robo2: A Potential Drug Target and Biomarker
Robo2 (Roundabout Homolog 2) is a gene that has been identified in various organisms as a potential drug target or biomarker. It plays a crucial role in the development and maintenance of muscle mass and has been linked to several diseases, including cancer.
Mutations in the Robo2 gene have been linked to a variety of diseases, including muscular dystrophy, myopathies, and neurodegenerative diseases. The muscle mass and function are critical for overall health and quality of life, and any changes in these areas can have a significant impact on an individual's quality of life.
The discovery of the Robo2 gene and its role in muscle mass development has led to a growing interest in using it as a drug target or biomarker. Several studies have investigated the effects of drugs on Robo2-positive muscles and have shown that these drugs can increase muscle mass and strength in individuals with muscle dystrophy or other myopathies.
In addition to its potential use as a drug target, Robo2 has also been investigated as a biomarker for several diseases. The muscle mass and function are critical for overall health and quality of life, and any changes in these areas can be indicative of underlying diseases.
Using Robo2 as a biomarker has the potential to revolutionize the field of diagnostic medicine. Instead of relying on invasive procedures, such as muscle biopsy or imaging, doctors can simply measure the muscle mass and function of their patients using non-invasive techniques. This could lead to earlier detection of diseases and more personalized treatment plans.
The Robo2 gene has also been linked to several other genes that have been implicated in cancer. The muscle mass and function are critical for the development and maintenance of healthy tissues, and any changes in these areas can be a sign of underlying cancerous changes.
In conclusion, Robo2 is a gene that has the potential to be a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its role in muscle mass and function and its potential as a drug or biomarker.
Protein Name: Roundabout Guidance Receptor 2
Functions: Receptor for SLIT2, and probably SLIT1, which are thought to act as molecular guidance cue in cellular migration, including axonal navigation at the ventral midline of the neural tube and projection of axons to different regions during neuronal development
More Common Targets
ROBO3 | ROBO4 | ROCK1 | ROCK1P1 | ROCK2 | ROCR | Rod cGMP phosphodiesterase 6 | ROGDI | ROM1 | ROMO1 | ROPN1 | ROPN1B | ROPN1L | ROR1 | ROR1-AS1 | ROR2 | RORA | RORA-AS1 | RORB | RORC | ROS1 | Roundabout homolog receptor | RP1 | RP1L1 | RP2 | RP9 | RP9P | RPA1 | RPA2 | RPA3 | RPA3P1 | RPA4 | RPAIN | RPAP1 | RPAP2 | RPAP3 | RPAP3-DT | RPE | RPE65 | RPEL1 | RPF1 | RPF2 | RPGR | RPGRIP1 | RPGRIP1L | RPH3A | RPH3AL | RPH3AL-AS1 | RPIA | RPL10 | RPL10A | RPL10AP10 | RPL10AP12 | RPL10AP3 | RPL10AP6 | RPL10AP7 | RPL10AP9 | RPL10L | RPL10P13 | RPL10P16 | RPL10P2 | RPL10P4 | RPL10P6 | RPL10P9 | RPL11 | RPL11P4 | RPL12 | RPL12P32 | RPL12P38 | RPL12P6 | RPL12P7 | RPL13 | RPL13A | RPL13AP16 | RPL13AP17 | RPL13AP20 | RPL13AP22 | RPL13AP23 | RPL13AP25 | RPL13AP3 | RPL13AP5 | RPL13AP6 | RPL13AP7 | RPL13P12 | RPL13P5 | RPL13P6 | RPL14 | RPL14P1 | RPL14P3 | RPL15 | RPL15P11 | RPL15P20 | RPL15P21 | RPL15P22 | RPL15P3 | RPL15P4 | RPL17 | RPL17P25 | RPL17P33 | RPL17P34